Pharmaceutical industry news

Adjunctive corticosteroids in herpes simplex virus encephalitis: a meta-analysis of randomized and observational studies.

Low-dose ticagrelor combined with aspirin for preventing early neurological deterioration in patients with high-risk non-disabling ischemic cerebrovascular events: a multicenter, prospective, randomized, open-label, clinical trial.

Selecting Vehicle Comparators in Dry Eye Disease Clinical Trials: Implications for Efficacy and Safety Assessment and Regulatory Outcomes.

A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol.

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

CNIC en la Noche Europea de los Investigadores 2026

ECL Unit Leader Leo Speidel elected a 2026 AYS Fellow in Life Sciences

#RASSEGNASTAMPA. Domenica “robotica” in #PoliclinicoMi. Un’attività del Servizio Pubblico raccontata anche dalle telecamere di Studio Aperto

Drug label update: Noicaky FUNGAL NAIL Patches

Official structured record identifier: 5adcc5f7-2d47-2ad7-e063-6294a90a4848.

Drug label update: Skin Wart Remover Liquid

Official structured record identifier: 5adc4d7e-0b07-bbfe-e063-6394a90af762.

Drug label update: Inlifay ANTIFUNGAL

Official structured record identifier: 4a832f39-ac11-d8b3-e063-6394a90acb39.

Drug label update: VERSACLOZ

Official structured record identifier: 2592c9a8-fd74-4e0d-a895-b07b014cf355.

A Systematic Review and Meta-Analysis of Malnutrition and Metabolic Failure in High-Potency Incretin Therapy.

Complete Response to Tislelizumab in an Elderly Patient With Metastatic Pulmonary Squamous Cell Carcinoma: Potential Synergy With Metformin and Multidisciplinary Management.

A Registry-Based Perspective of Interventional Clinical Trials for Duchenne Muscular Dystrophy.

The Governance Gap: Democratizing Drug Development Through Decision Architecture.

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real-World Data: The INVESTED-Medicare Linkage Study.

Incidence, pathogenesis, clinical manifestations, and pharmacological management of the 2026 Andes virus outbreak.

From Invisible to Enrolled: How Artificial Intelligence Is Reshaping Clinical Trial Recruitment.

Efficacy and Safety of the First Adalimumab Biosimilar in Chinese Children with Severe Plaque Psoriasis: The PISCES Study, a Multicenter Prospective Study.

The shelved pipeline: AI can find strategically abandoned medicines and bring them to patients.

UFRJ lamenta a morte do professor emérito Carlos Russo

FDA Recasts Drug Packaging Oversight with Science- and Risk-Based Container Closure Guidance

ORIC stock holds steady as biotech eyes next trial and earnings

VRXA Jumps As Traders Focus On Biotech Breakout Setup

Signant Health & Lothar Medical Sign LOI to Commercialize ALDS PRO for Clinical Trials

Annovis Bio stock reacts to webinar plan and steep discount to analyst targets

European healthcare professionals view greener pharmaceutical manufacturing favorably

SYNH stock reflects Syneos Health’s move to go private

Symbiosis Pharmaceutical Services appoints Jos Vergeest as senior business development director

The MS Pill That Beat Standard Therapy and Cleared the Safety Bar Its Rival Could Not

Before the First Molecule: Making Better Target and Modality Decisions

BPOM invites pharmaceutical industry to bolster clinical trials

Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation

FDA Approves First Drug for Alexander Disease

CRISPR Therapeutics gains FDA approval for CASG...

ETFs Investing in Beijing SL Pharmaceutical Co. Ltd. Class A Stocks

Nykredit A S Purchases New Position in Teva Pharmaceutical Industries Ltd. $TEVA

Adverum Biotech (ADVM) Free Cash Flow 2024: $92.8M outflow, down 1.2%

Medicines Discovery Catapult backs UK biotech innovators

Two scientists made huge bets on 'impossible' cancer treatments. They're finally paying off.

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Given Average Rating of "Moderate Buy" by Analysts

symbol__ Stock Quote Price and Forecast

SLS Stock Rises Overnight: Healthcare Execs Tout AML Drug As ‘Game Changer’ Ahead Of Final Trial Trigger

Inhibrx to Present INBRX-106 Phase 2 Data in Head and Neck Cancer Study

The Extra Year That Made All the Difference

Tarsus Pharmaceuticals Acquires Alkeus, Gildeuretinol for Stargardt Disease

Pelacarsen Fails to Meet Primary Endpoint in Phase 3 Lp(a) Trial

This Small-Cap Biotech Posted Impressive Brain Cancer Data – But There’s A Catch

BioMarin Pharmaceutical (BMRN), What Is Behind The Fresh Attention?

AstraZeneca’s Breast Cancer Drug Etcamah Gets US FDA Approval

Top 3 Japanese AI Healthcare Stocks To Watch In September 2026

Why Grand Pharmaceutical Group (SEHK:512) Is Back In The Spotlight

West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap

Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial

Why Ultragenyx Pharmaceutical (RARE) Is Down 40.3% After Angelman Trial Failure And Cost-Cut Plan

Aporte de EEUU ayudará a preservar el patrimonio del Observatorio Manuel Foster

Culture media alter retinal organoid physiology promoting AAV transduction and retinal ganglion cell survival

NIH award: Endoscopic versus Shunt Treatment of Hydrocephalus in Infants

Recipient: UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH. Award amount: 20739.

NIH award: Mexican Teachers Cohort Study: Genetics and Cognitive Function

Recipient: RUSH UNIVERSITY MEDICAL CENTER. Award amount: 1678461.